March 1st 2024
The offering reportedly helps avoid product quarantine.
February 22nd 2024
OneScan 7.1 is expected to boost compliance, while also improving pharma supply chain efficiencies.
January 31st 2024
A look at the challenges that need to be addressed during the FDA stabilization period.
January 18th 2024
The predicted value is largely driven by manufacturers' prioritization of brand protection.
EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.
The Struggle to Get Anti-Infectives on a Faster Track to Commercialization
A looming crisis in drug-resistant anti-infectives is not being met with a commensurate industry effort. Governments and industry are trying to cope
Rare Diseases and Orphan Drugs Lift Pharma Innovation
As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy
PDMA 2010: The Power of Sharing
The 2010 PDMA Sharing Conference: Expanding Our Focus With More Learning Opportunities
The Drive to Develop New Commercial Models
Industry’s coming challenges will force dramatic change on how products are brought to market and businesses are sustained. Industry leaders have already started the process
Site Selection 2010: Development Authorities Recalibrate Their Pitch as Biopharma Growth Slowly Rebounds
Faced with fierce competition, dwindling budgets and intense pressure to create jobs, economic development authorities are reinventing their recruitment strategies to attract life sciences employers
Optimization of 2-8 Degrees Celsius Controlled-Temperature Small Parcels
Patient Outcomes Research Moves Drug Development Beyond Clinical Results
Pharma Gets a 'Just in Time' Speedup With the Switch to Digital Printing
‘Print on demand’ changes traditional design, production and inventory practices for labels, inserts and other printed packaging
Putting Nursing Into the Pharmaceutical Usage Equation
While nurses move into a more central role in prescribing and administering pharmaceuticals, the nursing professions debate industry influence
The State of the Industry in Product Security
As legislative mandates have receded, manufacturers must undertake their own initiatives for protecting against counterfeits and diversion
Surveying the Mental Health Medication Landscape--Part 2
Central nervous system (CNS) medication for society’s oldest and youngest present special challenges
Surveying the Mental Health Medication Landscape - Part 1
Antipsychotic and antidepressant drugs have risen to the top categories of prescribed medications in a challenging and risky medical and regulatory arena
Workforce and Supply Chain Top Location Must-Have Lists for Biopharma
States continue to push for a ‘bio-economic’ foundation
Even While Regulatory Mandates Slip Into the Future, Brand Protection Needs Remain
Drugmakers recalibrate anti-counterfeiting and serialization efforts
A Pitched Battle in Cardiovascular Drug Marketing
Mature product franchises and mixed clinical outcomes have not dissuaded pharma companies from expending marketing resources for cardiovascular disease treatment
Building an Alternative Distribution Model for Ultra-Orphan Diseases
Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services
485 Route 1 South,Building F, Suite 210Iselin, NJ 08830